Nearly one in eight men will be diagnosed with prostate cancer and, as a new UCSF study finds, significantly more of these ...

PSA doubling time is an essential criterion for high-risk biochemically recurrent prostate cancer that should prompt treatment escalation.

The latest figures on prostate cancer are shocking: it has officially overtaken breast cancer as the most commonly diagnosed ...

OPTYX study shows many patients with advanced prostate cancer preferred oral relugolix over injectables for androgen deprivation therapy.

GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Devaki Surasi discussing combination sequencing for PSMA-based therapy in advanced disease. Dr. Surasi started with ...

(UroToday.com) The 2025 GU ASCO annual meeting featured a prostate cancer session and a presentation by Joseph Allen discussing PSA response and survival based on metastatic site in patients with ...

Adults 45 and older should start routine colorectal cancer screenings. People at higher risk due to family history or other factors should talk to their doctor about screening earlier. Regular ...

As the world marks the International Childhood Cancer Day (ICCD) today, childhood cancer survivors, families, and experts have called on the federal ...

SAN FRANCISCO -- Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when ...

Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...

A cancer survivor is a person who has received a cancer diagnosis in their lifetime. Being a "survivor" is not the same as ...